Filing status
- Accounts due
- 30 April 2027
- Last accounts
- 31 July 2025
- Conf. stmt due
- 20 May 2027
- Last conf. stmt
- 6 May 2026
Oxford Target Therapeutics Limited
- Incorporated
- 2 February 2022 (4 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Owned by
- Victor Martin Bolanos-Garcia
- Accounts type
- Total exemption full
- Region
- South East
- Address
- Bioinnovation HubTonge Building Oxford Brookes UniversityGipsy LaneHeadington CampusOxfordOX3 0BP
Officers
Current officers not loaded yet. See them on Companies House
Officer details are public data from the Companies House register.
Officer history (1 former)
11 November 2026
21 February 2025
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Victor Martin Bolanos-Garcia
Individual · Notified 2 February 2022
Owns 25–50% of shares
Holds 25–50% of voting rights
British
Born May 1965 (61)
Former controllers (1)
24 October 2024
Ceased Natalie Laura Curtis — Owns 25–50% of shares
Financials
Balance sheet as at 31 July 2025 · total exemption full accounts
- Cash
- £62,399
- Current Ratio
- 0.8x
Trend
Shareholder Funds
Balance sheet detail
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Fixed Assets | £212,757 | £113,734 | |
| Current Assets | £62,399 | £68,814 | £70,491 |
| Debtors | £0 | £12,535 | £66,844 |
| Cash | £62,399 | £56,279 | £3,647 |
| Creditors (< 1 year) | £79,062 | £78,225 | £108,003 |
| Net Current Assets | (£16,663) | (£9,411) | (£37,512) |
| Shareholder Funds | £196,094 | £202,791 | £76,222 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 11 November 2026 | Termination of appointment of a director |
Other companies in this industry
By trade and location
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →